Document is current
Any future updates will be listed below
-
Authors
Patel, Salma I.
Shamoun, Fadi E.
Esser, Heidi
Parthasarathy, Sairam
Ackerman, Michael J.
Geske, Jeffrey B.
Ommen, Steve R.
Love, William T.
Somers, Virend K.
Chahal, Anwar A.
Bos, Johan M.
Cha, Stephen S.
Lester, Steven J.
-
Funding
Funding for this research was provided by:
Mayo Clinic (Weinman Fund)
National Institutes of Health (HL134885, HL065176, HL095799, HL095748)
- License Information
-
More Information
Article History
Received: 11 July 2019
Revised: 21 October 2019
Accepted: 21 November 2019
First Online: 6 December 2019
Compliance with Ethical Standards
:
: Funding for this project has been via a Mayo Clinic Grant. Pertinent commercial or other sources of funding for the individual author(s): S.J. Lester: Consultant: MyoKardia; M.J. Ackerman: Consultant/Advisory Board; Modest; Boston Scientific, Gilead Sciences, Medtronic, and St. Jude Medical. Other; Significant; Transgenomic. V.K. Somers: consultant to U-Health, GlaxoSmithKline, Price Waterhouse Coopers, Rhonda Grey, Dane Garvin, Philips, ResMed, Sorin Inc., and is working with Mayo Health Solutions and their industry partners on intellectual property related to sleep and cardiovascular disease. All authors certify that there is no financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name the institution/committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this retrospective, study formal consent is not required.
